CNBC's Jim Cramer on Monday highlighted sectors that may benefit from the increased usage of GLP-1 drugs.
from US Top News and Analysis https://ift.tt/yjsCWrT
Cramer says the growing popularity of weight loss drugs brings new investing opportunities
December 05, 2023
0